Unique ID issued by UMIN | UMIN000035383 |
---|---|
Receipt number | R000040318 |
Scientific Title | Study of Blood Collection Catheter for Blood Glucose Management with Artificial Pancreas after Esophageal Surgery |
Date of disclosure of the study information | 2019/01/31 |
Last modified on | 2018/12/27 18:08:50 |
Study of Blood Collection Catheter for Blood Glucose Management with Artificial Pancreas after Esophageal Surgery
Catheter of artificial pancreas after esophagectomy
Study of Blood Collection Catheter for Blood Glucose Management with Artificial Pancreas after Esophageal Surgery
Catheter of artificial pancreas after esophagectomy
Japan |
esophageal cancer
Gastrointestinal surgery |
Malignancy
NO
To find optimum catheter for blood glucose control with artificial pancreas
Efficacy
Number of defective blood sampling
Problem solving method required when blood sampling failure.
Time taken to recover from blood sampling failure.
Percentage of blood sampling failures time during use of artificial pancreas .
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Device,equipment |
A group, intravenous indwelling catheters (Insight, 20 G, 30 mm) manufactured by Becton Dickinson Company
B group, intravenous indwelling catheter (Insight, 22 G, 32 mm) manufactured by Japan Becton Dickinson and Company
20 | years-old | <= |
85 | years-old | > |
Male and Female
1. Among patients who underwent esophageal resection, cases in which blood glucose control is performed.
2. A performance status of 0-2 accord
ing to the Eastern Cooperative Oncol
ogy Group (ECOG) scale.
3. An age of 20 years and over.
4. Patients who are considered to survive for more than 3 months from the registration.
5. Vital organ functions are preserved within 14 days prior to entry.
6. Sufficient oral intake.
7. All patients gave written informed
consent.
1. Obvious infection or inflammation.
2. Serious cardiovascular diseases.
3. Serious concurrent disease such as intestinal palsy, small bowel obstraction, uncontrolable diabetes mellitus, renal failure, liver cirrhosis, and so on.
4. Massive ascites beyond the pelvic cavity or pleural effusion.
5. Women who are pregnant or hope to become pregnant during the study period. Men who wish their partner to become pregnant.
6. Patients judged inappropriate for the study by their physicians.
20
1st name | |
Middle name | |
Last name | Hiroyuki Kitagawa |
Kochi Medical School
Department of Surgery
Kohasu, Okocho, nankoku, Kochi, 783-8505
088-880-2371
kitagawah@kochi-u.ac.jp
1st name | |
Middle name | |
Last name | Hiroyuki Kitagawa |
Kochi Medical School
Department of Surgery
Kohasu, Okocho, nankoku, Kochi, 783-8505
088-880-2371
kitagawah@kochi-u.ac.jp
Kochi Medical School
None
Self funding
NO
2019 | Year | 01 | Month | 31 | Day |
Unpublished
Preinitiation
2018 | Year | 12 | Month | 27 | Day |
2019 | Year | 01 | Month | 04 | Day |
2018 | Year | 12 | Month | 27 | Day |
2018 | Year | 12 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040318
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |